trolamine salicylate has been researched along with Infections, Coronavirus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Balduzzi, S; Bellis, E; Delvino, P; Montecucco, C; Monti, S; Quadrelli, VS | 1 |
Joob, B; Wiwanitkit, V | 1 |
Caporali, R; Cimaz, R; Costi, S | 1 |
Caporali, R; Del Papa, N; Minniti, A; Pignataro, F; Sambataro, G | 1 |
4 other study(ies) available for trolamine salicylate and Infections, Coronavirus
Article | Year |
---|---|
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Topics: Aged; Antirheumatic Agents; Arthritis; Betacoronavirus; Chronic Disease; Coronavirus Infections; COVID-19; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.
Topics: Antirheumatic Agents; Arthritis; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy.
Topics: Arthritis; Betacoronavirus; Child; Coronavirus Infections; COVID-19; Humans; Italy; Pandemics; Pneumonia, Viral; Rheumatology; SARS-CoV-2 | 2020 |
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
Topics: Arthritis; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Scleroderma, Systemic | 2020 |